First Trust Advisors’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$505K Buy
75,120
+2,631
+4% +$17.7K ﹤0.01% 2264
2025
Q1
$655K Sell
72,489
-1,260
-2% -$11.4K ﹤0.01% 2166
2024
Q4
$1.28M Sell
73,749
-7,800
-10% -$135K ﹤0.01% 1981
2024
Q3
$1.3M Buy
+81,549
New +$1.3M ﹤0.01% 1933